Q2 2026 Holdings
Filed 2026-08-11 | 463 holdings | $429.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Travere Therapeutics Inc(TVTX) | COM | 89422G107 | $1.3M | 22,346 | 0.3% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $1.3M | 15,605 | 0.3% |
| Crispr Therapeutics AG(CRSP) | NAMEN AKT | H17182108 | $1.3M | 23,351 | 0.3% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $1.3M | 40,155 | 0.3% |
| Leidos Holdings Inc(LDOS) | COM | 525327102 | $1.3M | 12,495 | 0.3% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $1.3M | 23,483 | 0.3% |
| Geron Corp(GERN) | COM | 374163103 | $1.3M | 1,011,201 | 0.3% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $1.3M | 68,124 | 0.3% |
| Eagle Point CR Co(ECC) | COM | 269808101 | $1.3M | 348,534 | 0.3% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $1.3M | 17,408 | 0.3% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $1.3M | 2,614 | 0.3% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $1.3M | 10,593 | 0.3% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $1.3M | 2,419 | 0.3% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $1.3M | 16,326 | 0.3% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $1.3M | 16,732 | 0.3% |
| Zymeworks Inc(ZYME) | COM | 98985Y108 | $1.3M | 50,825 | 0.3% |
| Biocryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $1.3M | 133,664 | 0.3% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $1.3M | 318,598 | 0.3% |
| Nuvation BIO Inc(NUVB) | COM CL A | 67080N101 | $1.3M | 236,358 | 0.3% |
| Oxford Lane Cap Corp(OXLC) | COM | 691543847 | $1.3M | 153,504 | 0.3% |
| Xeris Biopharma Holdings Inc(XERS) | COM | 98422E103 | $1.4M | 171,264 | 0.3% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $1.4M | 3,657 | 0.3% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $1.4M | 75,956 | 0.3% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $1.4M | 38,711 | 0.3% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $1.4M | 11,705 | 0.3% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $1.4M | 53,688 | 0.3% |
| Rigel Pharmaceuticals Inc(RIGL) | COM | 766559702 | $1.4M | 35,400 | 0.3% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $1.4M | 63,720 | 0.3% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $1.4M | 55,139 | 0.3% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $1.4M | 128,495 | 0.3% |
| CME Group Inc(CME) | COM | 12572Q105 | $1.4M | 6,394 | 0.3% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $1.4M | 16,577 | 0.3% |
| Ascendis Pharma A/S(ASND) | ORD SHS | K08588103 | $1.4M | 5,333 | 0.3% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $1.4M | 22,411 | 0.3% |
| Immunitybio Inc(IBRX) | COM | 45256X103 | $1.4M | 163,786 | 0.3% |
| Ligand Pharmaceuticals Inc(LGND) | COM NEW | 53220K504 | $1.4M | 4,551 | 0.3% |
| Newmont Corp(NEM) | COM | 651639106 | $1.5M | 15,528 | 0.3% |
| Carvana Co(CVNA) | CL A | 146869102 | $1.5M | 22,152 | 0.3% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $1.5M | 13,158 | 0.3% |
| Baker Hughes Company(BKR) | CL A | 05722G100 | $1.5M | 26,356 | 0.3% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $1.5M | 39,473 | 0.3% |
| Palantir Technologies Inc(PLTR) | CL A | 69608A108 | $1.5M | 12,594 | 0.3% |
| FOX Corp(FOXA) | CL A COM | 35137L105 | $1.5M | 28,224 | 0.3% |
| Precigen Inc(PGEN) | COM | 74017N105 | $1.5M | 261,322 | 0.3% |
| Meta Platforms Inc(META) | CL A | 30303M102 | $1.5M | 2,656 | 0.3% |
| Ulta Beauty Inc(ULTA) | COM | 90384S303 | $1.5M | 3,339 | 0.4% |
| Oracle Corp(ORCL) | COM | 68389X105 | $1.5M | 10,422 | 0.4% |
| LAS Vegas Sands Corp(LVS) | COM | 517834107 | $1.5M | 33,089 | 0.4% |
| Monolithic PWR SYS Inc(MPWR) | COM | 609839105 | $1.6M | 1,134 | 0.4% |
| Nasdaq Inc(NDAQ) | COM | 631103108 | $1.6M | 19,931 | 0.4% |